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Background: An epidemiological approach to preventing the development or progression of chronic kidney
disease (CKD) is necessary, while few effective preventive measures are currently available. We conducted a
community-based, cohort study to identify the factors associated with the development of CKD in the general
population.
Methods: We examined 1876 local residents of a Japanese community who had an annual health check-up and, of
those, 1506 residents judged not to have CKD (473 men and 1033 women) were followed for the development of
CKD over 10 years.
Results: The numbers of male and female residents who developed CKD during the follow-up period were 167
(35.3%) and 299 (28.9%), respectively. As compared to those without CKD development, the residents who
developed CKD were older, and had a higher body mass index (BMI), systolic blood pressure, and creatinine in both
genders. The rate of CKD development in obese female residents was higher than in non-obese women, but such
a difference was not noted in male residents. In addition to age and serum creatinine, we identified BMI as an
independently significant factor for the development of CKD in women, but not in men.
Conclusions: Increased BMI is a significant risk factor for the development of CKD in women, and there seems to
be a gender difference in the association between increased BMI and the development of CKD in the general
population.
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Chronic kidney disease (CKD) is defined as either struc-
tural and/or functional abnormality of the kidney or a re-
duced glomerular filtration rate (GFR) to <60 ml/min/
1.73 m2 [1,2]. CKD has recently been recognized as a chal-
lenging public health issue not only because the number
of patients with end-stage renal disease (ESRD) is steadily
increasing in developed countries including Japan, but also
because epidemiological studies have shown that CKD is a
significant risk factor for cardiovascular disease [3-5]. For
example, the number of ESRD patients in Japan is cur-
rently some 300,000, and this has become an economic* Correspondence: jkjpn@med.miyazaki-u.ac.jp
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reproduction in any medium, provided the orburden for the health care system [6]. On the other hand,
it was shown in a Japanese community by a prospective
study that ischemic heart disease and cerebral infarction
are more frequent in male and female residents with
CKD, respectively, than in those without [5]. In order to
prevent or reduce the development of CKD at a commu-
nity level, it is essential to identify or specify the causes of
CKD. Possible factors shown to be involved in the devel-
opment of CKD are age, hypertension, impaired glucose
tolerance or diabetes mellitus, dyslipidemia and obesity
[7-16]; however, the detailed mechanisms remains to be
clarified, and we currently have few effective countermea-
sures to prevent the development or progression of CKD
at a community level. According to our previous cross-
sectional study, body mass index (BMI) was found to be
an independently, significant factor for CKD, in additionl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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a Japanese community [17]. In the present study, we
followed the local residents of that area, who had been
judged not to have CKD, for 10 years to identify the
factors associated with future development of CKD in a
general population.
Methods
In this study, we examined local residents in the Kiyotake
area, Miyazaki, Japan, who had an annual health check-up
in October 1999, responding to the recommendations
made by the municipal government for those of 40 years
or older. Upon visiting the community center of Kiyotake
town, blood pressure was measured with an oscillometric
automatic device (BP-103iII; Colin, Tokyo, Japan) in a
sitting position by experienced nurses. Then, urine was
collected and blood was drawn from an antecubital vein.
Serum lipid and glucose levels were measured by an
automatic analyzer (AU2700; OLYMPUS, Tokyo, Japan)
with serum creatinine levels determined by an enzy-
matic method. GFRs were calculated with the formula of
the Japanese Society of \Nephrology: 194 × serum crea-
tinine- 1.094 × age-0.287 ml/min/1.73 m2, further multiplied
by 0.739 for women [18]. Residents were judged to have
CKD when the estimated GFR was <60 ml/min/
1.73 m2 or spot urine protein determined by dipstick
measurement was ≥ +1 (30 mg/dl). Obesity was defined
as BMI ≥25 kg/m2, according to the criteria of the Japan
Society for the Study of Obesity [19]. In this health check-
up program, 1876 residents (615 men and 1261 women;
58.7 ± 11.6 years; mean ± S.D.) visited during the time
period mentioned above. Of those receiving the check-upTable 1 Basal profiles of male and female residents with or w
Men
Development of CKD (−)
n 306
Age (years) 58.0 ±11.5
Body mass index (kg/m2) 22.8 ± 2.9
Obesity (%) 21.6
Systolic blood pressure (mmHg) 124 ± 18
Diastolic blood pressure (mmHg) 76 ± 11
Total cholesterol (mg/dL) 195 ± 32
HDL-cholesterol (mg/dL) 57 ± 15
Triglyceride (mg/dL) 106 ± 73
Fasting blood glucose (mg/dL) 93 ± 15
AST (IU/L) 26 ± 8
ALT (IU/L) 24 ± 13
γ-GTP (IU/L) 43 ± 50
Creatinine (mg/dl) 0.71 ± 0.09
AST, aspartate aminotransferase; ALT, alanine aminotransferase; GTP, glutamyl transin 1999, 1506 residents, who were judged not to have
CKD (473 men and 1033 women; 58.2 ± 11.0 years), were
followed up for the development of CKD over 10 years at
the annual health check-ups held by the municipal gov-
ernment. The residents receiving the annual health check-
ups had been notified of the results by mail every year.
This study was approved by the Review Committee of
Cooperative and Commissioned Research and the Ethics
Committee of the University of Miyazaki Faculty of
Medicine. The check-up programs are carried out by the
municipal government according to Japanese law. In the
present study, we used the database of the municipal
government, from which it was impossible for us to
identify individual residents. Therefore, written informed
consent was not obtained individually, but instead, the
local residents were informed of this study via a local
newspaper issued by the municipal government, as re-
quired by the Ethics Committee.
All the data were analyzed with IBM SPSS software
version 20.0 (IBM, Armonk, NY, USA). Two groups
were compared by the unpaired t-test or chi-squared
test. The Kaplan-Meier method and log rank test were
used to see differences in the development of CKD be-
tween obese and non-obese residents. The relationships
between the development of CKD and the other parame-
ters were tested by Cox proportional hazard models. All
data are expressed as the means ± S.D. and P <0.05 was
considered to be significant.
Results
Table 1 shows the basal profiles of the male and female




64.6 ± 8.9** 56.2 ± 10.6 59.6 ± 11.1**
23.4 ± 3.0* 22.1 ± 3.0 23.0 ± 3.2**
28.1 16.5 24.1**
132 ± 18** 122 ± 17 125 ± 18**
78 ± 10* 73 ± 10 74 ± 10
194 ± 34 205 ± 33 207 ± 34
56 ± 15 64 ± 15 62 ± 15
103 ± 52 88 ± 45 94 ± 56
97 ± 17* 90 ± 12 90 ± 10
27 ± 11 22 ± 7 24 ± 9*
26 ± 22 18 ± 10 20 ± 17
58 ± 96 21 ± 22 22 ± 21
0.78 ± 0.12** 0.51 ± 0.08 0.59 ± 0.09**
peptidase; means ± S.D.; *P < 0.05, **P < 0.01, vs. without development of CKD.
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CKD during 1999 to 2009, the diagnosis of which was
made by estimated GFR <60 ml/min/1.73 m2 in 268 resi-
dents, by dipstick proteinuria ≥ +1 in 188 or by both in
10. The development of CKD in male residents (35.3%)
was more frequent (P <0.05) than in female residents
(28.9%). The residents who had developed CKD were
older, showing higher systolic blood pressure and serum
creatinine than those without CKD development, in both
genders. Additionally, fasting blood glucose in men and
aspartate aminotransferase (AST) in women were higher
in those with CKD development. BMI in male and fe-
male residents who developed CKD was higher, and
obesity was significantly more prevalent in women than
in those who did not develop CKD. In the Kaplan-Meier
analysis (Figure 1), no significant difference in CKD de-
velopment was noted between obese and non-obese
male (A), but CKD occurred more frequently in obese
than in non-obese women (B). Comparable with this,
there was no difference in newly developed proteinuria
between obese and non-obese male residents (16.8 vs.
16.7%), while development of proteinuria during the
follow-up period was more frequent in obese than in
non-obese women (20.2 vs. 11.7%, P < 0.01).
Next, we analyzed the development of CKD by Cox pro-
portional hazard models with single or multiple covari-
ates, as shown in Tables 2 and 3. In univariate analysis,
age, systolic and diastolic blood pressure, aspartate amino-
transferase (AST), and creatinine levels were found to be
significant covariates for CKD development in both gen-
ders. Also shown to be significant were fasting blood glu-
cose levels in male residents and triglyceride in female
residents. BMI was judged to be a significant factor in fe-
male residents but not in male residents. We then con-
ducted multivariate analyses, where clinical parameters
were used as independent covariates if they were signifi-
cantly different between residents with and without




























Figure 1 Kaplan-Meier analyses for the development of CKD in malefactor by univariate analyses. As shown in the right col-
umns of Tables 2 and 3, age and serum creatinine were
significant in both genders, but similar to univariate
analysis, BMI was extracted as a significant factor only
in female residents.
Discussion
Chronic kidney disease (CKD) has recently been recog-
nized not only as a risk factor of ESRD, but also of car-
diovascular disease, which is a leading cause of death in
developed countries [3-5]. An interventional approach is
necessary to prevent the development or progression of
CKD, while a number of factors have been reported to
be involved in the development of CKD and currently
there are few specific countermeasures against CKD at
community levels. Obesity has been shown to be an im-
portant factor associated with CKD [10,14,16,20,21], and
indeed, according to our previous, community-based,
cross-sectional study [17], BMI was found to be signifi-
cant for CKD in the Kiyotake area, a Japanese commu-
nity, in both genders. We therefore conducted this
cohort, 10-year follow-up study with local residents
without CKD in the same area, and found that an in-
crease in BMI was independently and significantly asso-
ciated with the development of CKD only in women.
It has been suggested that a number of factors are as-
sociated with the development of CKD: these are male
gender, age, hypertension, impaired glucose tolerance or
diabetes mellitus, dyslipidemia, obesity, and smoking
[7-16]. Accordant with those reports, the development
of CKD was more frequent in male residents than in fe-
male residents, and age was determined to be a signifi-
cant factor of CKD development in both genders in the
present study. Obesity is closely associated with hyper-
tension, diabetes mellitus, and dyslipidemia, all of which
are detrimental factors to renal function [7-12]. Indeed,
systolic and diastolic blood pressure levels were signifi-


























(A) and female (B) residents.
Table 2 Identification of factors associated with
development of CKD in male subjects
Male Univariate Multivariate
RR (95% CI) RR (95% CI)
Age (years) 1.058 (1.041-1.075)** 1.051 (1.032-1.070)**
Body mass index (kg/m2) 1.038 (0.987-1.092) 1.035 (0.978-1.096)
Systolic blood pressure (mmHg) 1.020 (1.012-1.029)** 1.008 (0.996-1.021)
Diastolic blood
pressure (mmHg)
1.019 (1.004-1.034)* 1.002 (0.981-1.023)
Total cholesterol (mg/dL) 0.999 (0.995-1.004)
HDL-cholesterol (mg/dL) 0.996 (0.986-1.006)
Triglyceride (mg/dL) 0.999 (0.997-1.002)
Fasting blood glucose (mg/dL) 1.012 (1.004-1.019)** 1.009 (0.999-1.018)
AST (IU/L) 1.016 (1.001-1.031)* 1.001 (0.979-1.023)
ALT (IU/L) 1.005 (0.996-1.013)
γ-GTP (IU/L) 1.002 (1.000-1.003)* 1.002 (1.000-1.004)
Creatinine (mg/dl) 160 (33–785)** 101 (20–522)**
RR, risk ratio; AST, aspartate aminotransferase; ALT, alanine aminotransferase;
GTP, glutamyl transpeptidase; *P < 0.05, **P < 0.01.
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be significant were the levels of fasting blood glucose in
men and those of triglycerides in women. Meanwhile,
obesity has recently been shown to be a risk factor for
the development or progression of CKD, which is inde-
pendent of the other risks mentioned above [13,16,22].
Possible mechanisms of this obesity-induced renalTable 3 Identification of factors associated with
development of CKD in female subjects
Female Univariate Multivariate
RR (95% CI) RR (95% CI)
Age (years) 1.034 (1.022-1.046)** 1.030 (1.017-1.044)**
Body mass index (kg/m2) 1.080 (1.042-1.119)** 1.048 (1.008-1.089)*
Systolic blood
pressure (mmHg)
1.012 (1.005-1.018)** 1.008 (0.998-1.019)
Diastolic blood
pressure (mmHg)
1.012 (1.000-1.023)* 0.995 (0.978-1.012)
Total cholesterol (mg/dL) 1.002 (0.999-1.005)
HDL-cholesterol (mg/dL) 0.993 (0.985-1.000)
Triglyceride (mg/dL) 1.002 (1.000-1.004)* 0.999 (0.997-1.002)
Fasting blood glucose (mg/dL) 1.005 (0.996-1.014)
AST (IU/L) 1.015 (1.002-1.028)* 1.003 (0.988-1.018)
ALT (IU/L) 1.006 (0.999-1.014)
γ-GTP (IU/L) 1.001 (0.997-1.006)
Creatinine (mg/dl) 6290 (1472–26882)** 6870 (1549–30470)**
RR, risk ratio; AST, aspartate aminotransferase; ALT, alanine aminotransferase;
GTP, glutamyl transpeptidase; *P < 0.05, **P < 0.01.damage are fat tissue-derived factors detrimental to renal
function, such as tumor necrosis factor-α, interleukin-6
and plasminogen activator inhibitor-1 [22].
An interesting finding of the present study was a gen-
der difference in the relationship between the develop-
ment of CKD and obesity or BMI. As shown in the basal
profiles of the study subjects (Table 1), BMI in the resi-
dents with CKD development was higher than in those
without in both genders; however, significant associa-
tions between CKD development and BMI or obesity
were found only in women by Kaplan-Meier and univar-
iate or multivariate analyses. A similar finding was ob-
served by Yamagata et al. [15], who reported that obesity
was a significant factor for CKD development only in
women in a Japanese community, although no further
data, including BMI, were available in their paper. We
examined male and female obese residents with basal or
metabolic parameters possibly involved in the develop-
ment of CKD, but failed to find any clear difference be-
tween these two groups (data not shown); therefore,
there seem to be no clear explanations for the gender
difference in CKD development observed in the present
study. This important point is discussed below in com-
parison with the results from cohort studies of subjects
without CKD and from cross-sectional studies.
We previously conducted a cross-sectional study of
local residents of the same community as examined in
the present study, and found a significant relationship
between CKD and BMI, which was independent of age
and other cardiovascular risk factors in both genders
[17]. Meanwhile, Ishizaka et al. and Shankar et al. per-
formed similar cross-sectional community-based studies,
showing significant relationships between CKD and BMI
in men but not in women, suggesting the susceptibility
of obese men to CKD in comparison with obese women
[20,21]. The findings of these studies appear to contra-
dict those of the present study, where obese women
were prone to CKD compared with non-obese women,
but such a difference was not noted in men. Possible
explanations for this discrepancy are as follows. First,
the present study is a cohort study where subjects with-
out CKD were followed up over 10 years, hence, both
the study design and the study subjects were essentially
different. Second, the age of the subjects may be a fac-
tor: the mean age of the subjects in those studies was
around 60 years, while in the present study, residents of
a similar age range were followed over 10 years. A rela-
tionship between CKD and obesity might have been
found in men if younger subjects had been followed for
a certain period of time. In an attempt to prove this, we
analyzed the data of male residents younger than
60 years, but the number of subjects was relatively
small (n = 189) and no significant difference was noted
in CKD development between obese and non-obese
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future studies.
Lastly, we need to mention the limitations of the
present study. First, there might have been a selection
bias because the local residents examined in this study
were those who received a health check-up responding
to the recommendations made by the municipal govern-
ment. For example, because the present subjects had
relatively lower BMI with smaller standard deviations
than in other studies [12,21], the remainder of the gen-
eral population might have different risk factors for
CKD development. Additionally, a type 2 statistical
error cannot completely be excluded from the gender
difference: the number of male residents examined was
smaller than that of female residents, while the Kaplan-
Meier curves of CKD development differed between
male and female residents with substantially different p
values (Figure 1). Second, the subjects examined in this
study were ethnically Japanese; therefore, caution
should be taken when the present findings are discussed
in comparison with other races or ethnic groups. Third,
no data were available regarding whether the study sub-
jects had hypertension or diabetes mellitus, important
factors in CKD development, at enrollment in this
study; instead, the data were adjusted by blood pressure
and fasting blood glucose levels.
Conclusions
Increased BMI was significantly associated with the de-
velopment of CKD in female residents in the general
population, while such a relationship was unclear in
male residents, suggesting a possible difference in sus-
ceptibility to CKD associated with obesity. Interventional
studies or approaches are warranted to see the effect of
body weight reduction on the development of CKD at
community levels.
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